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Abstract 
Introduction: Pediatric oncology patients are at increased risk of contracting healthcare-associated infections (HAIs), which are responsible 
for increased morbidity and mortality rates as well as treatment costs.  This study aimed to identify the frequency of HAIs among pediatric 
oncology patients and their outcome.  
Methodology: Pediatric oncology patients admitted between January 2009 and June 2010 in a pediatric ward at Aga Khan University 
Hospital, Karachi, Pakistan, who developed HAIs, were analyzed.  
Results: A total of 90 HAIs were identified in 32 patients in 70 admissions. The HAI rate among pediatric oncology patients was 3.1/100 
admission episodes. Bloodstream infections (63 episodes, 90.0%) were the most common, followed by urinary tract infection (two episodes, 
2.9%). Gram-positive infections were seen in 54 (60%) patients, followed by Gram-negative infection in 34 (37.8%), and fungi in 2 (2.8%) 
cases. Coagulase negative staphylococci was the most common Gram-positive and Escherichia coli and Pseudomonas aeruginosa were most 
common Gram-negative infections. Mortality rate among pediatric oncology patients who developed HAIs was 12.5% (4/32). Total parental 
nutrition use and length of stay longer than 30 days were the identified risk factors associated with increased mortality among pediatric 
oncology patients who developed HAIs.  
Conclusion: We report an HAI rate among pediatric oncology patients of 3.1/100 admission episodes with a mortality rate of 12.5% in 
Pakistan. Further studies should be done, especially in the developing world, to identify the risk factors associated with increased mortality 
among pediatric oncology patients so that adequate measures can be taken to reduce the mortality among these patients. 
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Introduction 
Healthcare-associated infections (HAIs) represent 
a worldwide health-care problem placing a 
substantial burden on both individual patients and on 
health-care systems, which results in major 
complications of serious illnesses [1]. However, 
employing new strategies such as the increased use of 
chemotherapy drugs, white blood cell stimulants, and 
broad-spectrum antibiotics has improved the outcome 
of pediatric oncology patients [2]. In spite of such 
advances, these patients experience long bouts when 
they are immunocompromised and must remain in 
hospital for long periods when they will likely 
require central venous catheterizations, urinary 
catheterizations, endotracheal intubations, and 
intravenous feeding tubes [2]. These factors 
moreover put oncology patients at an increased risk 
of contracting HAIs and substantially increase 
morbidity and mortality rates as well as treatment 
costs [2-4]. 
The incidence rate of HAI among pediatric 
oncology patients ranges from 5.2 to 13.3 per 100 
hospital admissions and 7.0 to 17.7 per 1000 
hospitalization days [2,3,6,7]. Some investigators 
report bloodstream infections (BSIs), while others 
report respiratory infections as the most frequent site 
of HAIs among pediatric oncology patients [2,5,7,8]. 
Gram-negative bacteria has been isolated most 
often in some investigations involving pediatric 
oncology patients, with Pseudomonas aeruginosa 
being the most common organism detected [5]. 
However, in other studies, a higher incidence of 
Gram-positive bacteria has been found with 
staphylococci being the most commonly detected 
organism [3,7]. Developing countries like Pakistan 
represent different health and environmental issues 
which might affect on rate of HAIs among high risk 
populations such as pediatric oncology patients. It 
would be interesting to assess the frequency of HAIs 
among pediatric oncology patients, infection sites, 
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and common microorganisms. Therefore, we 
conducted a retrospective surveillance study to 
identify the frequency of HAIs among pediatric 
oncology patients, the most common sites of 
infection, and organisms responsible for it in a 
hospital in Pakistan. 
 
Methodology 
Setting 
This descriptive, cross-sectional study was 
conducted in the Department of Pediatrics and Child 
Health, in the oncology unit, at Aga Khan University 
Hospital in Karachi, Pakistan, from January 2009 to 
June 2010. The Aga Khan University Hospital 
(AKUH) is a 600-bed tertiary-care facility and is 
accredited by the international arm of the Joint 
Commission International Accreditation Survey 
(JCIA). There is a 10-bed, separate oncology ward 
along with a 5-bed special care unit within the 
Pediatric Department, run by the pediatric residents 
and pediatric oncology fellows under the supervision 
of a pediatric hematologist and oncologist.. 
 
Patient population 
Pediatric oncology patients one month to 18 
years of age, who were admitted to the pediatric ward 
from January 2009 to June 2010, and who developed 
HAIs according to definitions set by the United 
States Centers for Disease Control and Prevention 
(CDC)/National Health Care Safety Network 
(NHSN) Guidelines [9] were included in the study. 
All patients received therapy according to 
ACCM/PALS 2002 [10] Guidelines for pediatric 
sepsis and multi-organ dysfunction [11].  
 
Definitions 
HAI, bloodstream infection (BSI), urinary tract 
infection (UTI), ventilator associated pneumonia 
(VAP), pneumonia in immunocompromised patients 
(PNEU3), and gastrointestinal tract infection (GIT) 
were all defined according to the criteria established 
by CDC/NHSN Guidelines [9]. Sepsis related 
diagnosis was made according to the criteria 
established at the International Pediatric Sepsis 
Consensus Conference [11]. 
 
Data collection 
All pediatric oncology patients, one month to 18 
years of age, who were admitted to the pediatric ward 
from January 2009 to June 2010, and who developed 
HAIs according to guidelines set by the Centers for 
Disease Control and Prevention (CDC)/National 
Health Care Safety Network (NHSN) [9] were 
registered in the study. Informed consent was taken 
from the guardian or parents. The data included 
demography of the patients’ registration number, age, 
gender, weight, and height. Data also included 
primary diagnosis, site of HAIs, and common 
organism responsible for it. Clinical data, i.e. 
temperature, heart rate, blood pressure, and pertinent 
laboratory data such as hemoglobin, total leukocyte 
counts, absolute neutrophil counts, and platelet 
counts were also included to identify the sepsis 
related diagnosis according to the guidelines of the 
International Pediatric Sepsis Consensus Conference 
[11]. Length of stay, history of blood transfusion, 
total parental nutrition (TPN), mechanical ventilation 
(MV), central venous catheters (CVC), and urinary 
catheter usage were also identified. The final 
outcome in terms of discharge from the ward or 
expired was identified. 
 
Statistical analysis 
The overall frequency of pediatric oncology 
patients who developed HAIs during the study period 
was determined by dividing the total number of 
admissions to pediatric oncology patients with HAIs 
with the total number of admissions to the pediatric 
oncology unit. For analysis, SPSS version 16 (IBM, 
Chicago, USA) was used. Descriptive frequencies 
were computed for qualitative variables and mean, 
and ranges were computed for quantitative variables. 
Pediatric oncology patients who survived after 
developing HAIs were compared with those who 
expired after developing HAIs and chi square was 
used to calculate the P value among these patients.  
 
Results 
The total number of admissions in the pediatric 
oncology unit was 2,241. A total of 90 episodes of 
HAIs were identified in 32 patients in 70 admissions. 
The HAI rate among pediatric oncology patients was 
3.1 HAI /100 admissions. Most of the patients had 
acute leukemia and lymphomas 62/70 (88.6%), 
followed by solid tumors (Table 1). The 
characteristics of patients who developed HAIs are 
given in Table 2. More than 50% of the patients had 
hemoglobin counts less than 10gm/dl, white blood 
count less than 1000/cm, absolute neutrophilic count 
(ANC) less than 500/cm, and platelet counts less than 
50,000/cm. Central venous catheter (CVC) was 
present in 46 out of 70 (65.7%) patients, in which  
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38/46 (82.6%) were portal catheter, 7/46 (15.2%) 
were peripherally inserted central catheter (PICC) 
line, and 1/46 (2.1%) was femoral line. The most 
common type of infection was bloodstream infection 
(BI) 63/70 (90%), followed by urinary tract infection 
(UTI). Gram-positive organisms constituted 54/90 
(60%) isolates, followed by Gram-negative 
organisms at 34/90 (37.8%), and fungi at 2/90 
(2.2%). Coagulase negative staphylococci were the 
most common Gram-positive bacteria, and 
Escherichia Coli and Pseudomonas aeruginosa were 
the most common Gram-negative organisms details 
(Table 3). The mortality rate among pediatric 
oncology patients who developed HAIs was 12.5% 
(4/32). Total parental nutrition (TPN) use and length 
of stay longer than 30 days with significant P values 
were the only identified risk factors associated with 
increased mortality among patients who developed 
HAI (Table 4).  
 
Discussion 
We report a lower frequency of HAIs among 
pediatric oncology patients compared to the rates of 
5.2-13.3/100 hospital admissions observed in 
previously reported studies [2,3,5,6]. The frequency 
of HAIs in our cohort was relatively low because we 
did not include the clinical CDC/NHSN criteria, as 
our cohort only included the culture-positive results 
according to CDC/NHSN criteria [9].  
In our study, BSI (90%) was the most common 
HAI, as seen in other cohorts [2,3,7,12]. The most 
common organism detected in our patients was 
Gram-positive bacteria, a finding that supports the 
reported trend of Gram-positive bacterial 
predominance since the 1980s, [3,13,14], with 
coagulase-negative staphylococci being the most 
common bacteria detected, as seen in other cohorts  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
[3,7,15]. The higher rate of Gram-positive bacteria as 
causal organism for HAIs in European countries 
could be due to the fact that in European countries 
central venous catheterization is a commonly 
performed procedure, as seen in our patients. In our 
cohort, greater than 70% were severely neutropenic, 
which might explain the risk factor associated with 
fungal infections; however, it was difficult to 
calculate positive correlation due to the small number 
of fungal infected samples. Therefore, as noted in one 
study involving oncology patients who had low 
absolute neutrophil counts for a prolonged period of 
time, care should be taken to guard against bacterial 
as well as fungal infections [16]. 
We report a mortality rate of 12.5%, which is 
lower than that reported in another investigation 
which showed a mortality rate of 19.6% [2]. 
Although we found TPN use and length of stay 
greater than 30 days to be statistically significant 
with a high mortality rate among pediatric oncology 
patients, we were not able to calculate the other risk 
factors associated with it because of the low mortality 
rate in our study; however, this observation suggests 
another area for future research.  
In conclusion, we report a low HAI rate among 
pediatric oncology patients from a hospital in 
Pakistan. We identified TPN use and length of stay 
longer than 30 days to be the associated risk factors 
leading to increased mortality among pediatric 
oncology patients. However, further studies had to be 
done to identify the risk factors associated with high 
mortality rate among pediatric oncology patients, 
especially in the developing world, so that adequate 
measures should be taken to reduce the mortality and 
health care costs.  
  Number n (%) 
Acute leukemia 51 (72.9) 
               Acute Lymphoblastic Leukemia  37 (52.9) 
               Acute Myeloid Leukemia 14 (20.0) 
Lymphoma 11 (15.7) 
              Non Hodgkin Lymphoma 10 (14.3) 
              Hodgkin disease 1 (1.4) 
Solid tumors 8 (11.3) 
             Synovial carcoma 5 (7.1) 
             Osteogenic sarcoma 1 (1.4) 
             Hepatoblastoma 1 (1.4) 
             Rhabdomyosarcoma 1 (1.4) 
Table 1. Diagnosis of admitted pediatric oncology patients who developed HAI  
 
(n =70) 
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Characteristics  Number (%) or Mean (Range) 
Age in years  6.5year (1-16.5) 
1 month - 5 years  31 (44.3) 
5 years - 10 years  27 (38.6) 
10 years - 18 years  12 (17.1) 
Male  45 (64.5) 
Weight (kg)  20.9 (5-51.5) 
Height (cm)  108.8 (74 - 150) 
Site of infection BSI 63 (90) 
 
UTI 2 (2.9) 
 
BSI + PNEU 3 2 (2.9) 
 
BSI + VAP 2 (2.9) 
 
GIT 1 (1.4) 
Sepsis related diagnosis Sepsis 67 (95.8) 
 
MOD 3 (4.2) 
Hemoglobin (gm/dl) < 10gm/dl 60 (85.7) 
 
> 10gm/dl 10 (14.3) 
WBC /cm < 1000/cm 38 (54.3) 
 
> 1000/cm 32 (45.7) 
ANC /cm < 500/cm 51 (72.9) 
 
> 500/cm 19 (27.1) 
Platelets /cm < 50,000/cm 38 (54.3) 
 
> 50,000/cm 32 (45.7) 
Length of stay (days)  18.2 (4-102) 
TPN given  17 (24.2) 
Blood transfusion  60 (85.7) 
CVC  46 (65.7) 
Porta catheter  38 (82.6) 
PICC line n (%)  7 (15.2) 
Femoral line  1 (2.1) 
Mechanical ventilation  4 (5.7) 
Foleys catheter  4 (5.7) 
Outcome Discharged 66 (94.3) 
 
Expired 4 (5.7) 
 
Table 2. Characteristics of admitted pediatric oncology patients who developed HAI (n = 70) 
HAI: Hospital acquired infection; BSI: Blood stream infection; UTI: Urinary tract infection, PNUE3: Pnuemonia in 
immunocompromised; VAP: Ventilator associated pnuemonia; GIT: Gastrointestinal tract infection; MOD: Multiorgan dysfunction; 
WBC: White blood cells; ANC: Absolute neutrophil counts; TPN: Total parentral nutrition; CVC: Central venous catheter 
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  Number (%) 
Gram positive organisms 54(60) 
          Coagulase negative staphylococci 37 (40.7) 
          Staphylococcus aureus 4 (4.4) 
          Streptococcus Species 7 (7.8) 
          Corynebacterium Species 5 (5.6) 
          Bacillus species 4 (4.4) 
Gram negative organisms 34 (37.8) 
          Escherichia coli 7 (7.8) 
          Pseudomonas aeruginosa 7 (7.8) 
          Klebsiella pneumoniae 6 (6.7) 
          Acinetobacter Species 4 (4.4) 
          Enterobacter Species 4 (4.4) 
          Pseudomonas cepacia 1 (1.1) 
          Pseudomonas stutzeri 1 (1.1) 
          Stenotrophomonas maltophilia 1 (1.1) 
Fungi 2 (2.2) 
          Candida tropicalis 1 (1.1) 
          Aspergillus flavus 1 (1.1) 
 
  Discharged (n = 66) 
Expired 
 (n = 4) P value 
  Number (%) Number (%) 
 Male  41 (62.1) 4 (100) 0.289 
5 years - 10 years  24 (36.4) 3 (75) 0.165 
Hemoglobin  < 10gm/dl  56 (84.8) 4 (100) 0.251 
WBC  < 1000/cm  34 (51.5) 4 (100) 0.222 
ANC < 500/cm  47 (71.2) 4 (100) 0.637 
Platelets < 50,000/cm  34 (51.5) 4 (100) 0.166 
Length of stay (> 30 days) 7 (10.6) 4 (100) 0.001 
TPN given  13 (19.7) 4 (100) 0.035 
Blood transfusion  56 (84.8) 4 (100) 0.532 
CVC  42 (63.6) 4 (100) 0.627 
Table 3. Organisms isolated  
 
(n = 90) 
Table 4. Characteristics of admitted pediatric oncology patients with HAI who 
discharged and expired 
 
HAI: Hospital acquired infection; WBC: White blood cells; ANC: Absolute neutrophil counts; TPN: 
Total parentral nutrition; CVC: Central venous catheter 
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